
Tuoxin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings
Tuoxin Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and distribution of nucleosides and nucleotides. The company serves as a major global supplier of active pharmaceutical ingredients (APIs) and chemical intermediates. Its core product portfolio includes cytidine, inosine, guanosine, adenosine, and their various derivatives, which are essential components in the synthesis of antiviral, anti-tumor, and cardiovascular medications. Notably, the group provides key intermediates for drugs such as Ribavirin and Azvudine. Tuoxin Pharmaceutical leverages advanced synthetic biotechnology and large-scale manufacturing capabilities to support the global pharmaceutical industry. The company maintains a focus on technological innovation and quality control to ensure the stability and purity of its chemical products for diverse therapeutic applications.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 董事、高级管理人员所持本公司股份及其变动管理制度 | 2025-08-26 | Chinese | |
| 独立董事专门会议议事规则 | 2025-08-26 | Chinese | |
| 独立董事工作制度 | 2025-08-26 | Chinese | |
| 董事会提名委员会工作条例 | 2025-08-26 | Chinese | |
| 重大信息内部报告制度 | 2025-08-26 | Chinese | |
| 年度报告重大差错责任追究制度 | 2025-08-26 | Chinese |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 39724282 | 董事、高级管理人员所持本公司股份及其变动管理制度 | 2025-08-26 | Chinese | ||
| 39724274 | 独立董事专门会议议事规则 | 2025-08-26 | Chinese | ||
| 39724265 | 独立董事工作制度 | 2025-08-26 | Chinese | ||
| 39724256 | 董事会提名委员会工作条例 | 2025-08-26 | Chinese | ||
| 39724254 | 重大信息内部报告制度 | 2025-08-26 | Chinese | ||
| 39724243 | 年度报告重大差错责任追究制度 | 2025-08-26 | Chinese | ||
| 39724230 | 互动易平台信息发布及回复内部审核制度 | 2025-08-26 | Chinese | ||
| 39724225 | 防范控股股东及关联方资金占用管理办法 | 2025-08-26 | Chinese | ||
| 39724222 | 关于2025年半年度计提资产减值准备的公告 | 2025-08-26 | Chinese | ||
| 39724212 | 董事会秘书工作管理制度 | 2025-08-26 | Chinese | ||
| 39724204 | 募集资金管理制度 | 2025-08-26 | Chinese | ||
| 39724196 | 对外担保管理制度 | 2025-08-26 | Chinese | ||
| 39724190 | 董事会审计委员会工作条例 | 2025-08-26 | Chinese | ||
| 39724181 | 总裁工作细则 | 2025-08-26 | Chinese | ||
| 39724169 | 信息披露管理制度 | 2025-08-26 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Tuoxin Pharmaceutical Group Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56042/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56042 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56042 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56042 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56042}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Tuoxin Pharmaceutical Group Co.,Ltd. (id: 56042)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.